Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor

Cell Growth and Differentiation

Volumn 7, Issue 2, 1996, Pages 213-221

  Sawano, Asako ^a   Takahashi, Tomoko ^a   Yamaguchi, Sachiko ^a   Aonuma, Masashi ^b   Shibuya, Masabumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; RECEPTOR SUBTYPE; VASCULOTROPIN;

ARTICLE; AUTOPHOSPHORYLATION; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME BINDING; ENZYME SPECIFICITY; GROWTH REGULATION; GROWTH STIMULATION; HUMAN; HUMAN CELL; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BACULOVIRIDAE; BASE SEQUENCE; BINDING, COMPETITIVE; CAPILLARY PERMEABILITY; DNA, COMPLEMENTARY; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM; EVANS BLUE; GENE EXPRESSION; GROWTH SUBSTANCES; GUINEA PIGS; HEPARIN; HUMANS; LYMPHOKINES; MICE; MOLECULAR SEQUENCE DATA; PREGNANCY PROTEINS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030050025     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Risau, W., Sariola, H., Zerwes, H-G., Sasse, J., Ekblom, P., Kemler, R , and Doetschman, T. Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies. Development (Camb.), 102: 471-478, 1988.
2. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
3. Michaelson, I. C. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans. Ophthalmol. Soc. UK, 68: 137-180, 1948.
4. Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J., and Leung, D. W. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem., 47: 211-218, 1991.
5. Shibuya, M. Role of VEGF-Flt receptor system in normal and tumor angiogenesis. Adv. Cancer Res., 67: 281-316, 1995.
6. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Washington DC), 219: 983-985, 1983.
7. Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H , and Sato, M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene, 5: 519-524, 1990.
8. De Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., and Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (Washington DC), 255: 989-991, 1992.
9. Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Bohlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res. Commun., 187: 1579-1586, 1992.
10. Matthews, W., Jordan, C. T., Gavin, M., Jenkins, N. A., Copeland, N. G., and Lemischka, I. R. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. USA, 88: 9026-9030, 1991.
11. Galland, F., Karamysheva, A., Pebusque, M-J., Borg, J-P., Rottapel, R., Dubreuil, P., Rosnet, O., and Birnbaum, D. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene, 8: 1233-1240, 1993.
12. Aprelikova, O., Pajusola, K., Partanen, J., Armstrong, E., Alitalo, R , Bailey, S. K., McMahon, J., Wasmuth, J., Huebner, K., and Alitalo, K. Flt4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. Cancer Res., 52: 746-748, 1992.
13. Eichmann, A., Marcelle, C., Breant, C., and Le Douarin, N. M. Two molecules related to the VEGF receptor are expressed in early endothelial cells during avian embryonic development. Mech. Dev., 42: 33-48, 1993.
14. Kaipainen, A., Korhonen, J., Pajusola, K., Aprelikova, O., Persico, M. G., Terman, B. I , and Alitalo, K. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J. Exp. Med., 178: 2077-2088, 1993.
15. Millauer, B , Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N. P. H., Risau, W., and Ullrich, A. High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72: 835-846, 1993.
16. Yamane, A., Seetharam, L., Yamaguchi, S., Gotoh, N., Takahashi, T , Neufeld, G., and Shibuya, M. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene, 9: 2683-2690, 1994.
17. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
18. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992
19. Quinn, T. P., Peters, K. G , De Vries, C., Ferrara, N., and Williams, L. T. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA, 90: 7533-7537, 1993.
20. Seetharam, L., Gotoh, N , Maru, Y., Neufeld, G., Yamaguchi, S., and Shibuya, M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene, 10: 135-147, 1995.
21. Waltenberger, J., Claesson-Welsh, L., Sieghalin, A., Shibuya, M., and Heldin, C-H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem., 269: 26988-26995, 1994.
22. Millauer, B., Shawver, L. K., Plate, K. H , Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant Nature (Lond.), 367: 576-579, 1994.
23. Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P., and Persico, M. G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. USA, 88: 9267-9271, 1991.
24. Maglione, D., Guerriero, V., Viglietto, G., Ferraro, M. G., Aprelikova, O., Alitalo, K., Vecchio, S. D., Lei, K-J., Chou, J. Y., and Persico, M. G. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PIGF), are transcribed from a single gene of chromosome 14. Oncogene, 8: 925-931, 1993.
25. Takahashi, A., Sasaki, H., Kim, S. J., Tobisu, K., Kakizoe, T., Tsukamoto, T., Kumamoto, Y., Sugimura, T., and Terada, M. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res., 54: 4233-4237, 1994.
26. Park, J. E., Chen, H. H., Winer, J., Houck, K. A., and Ferrara, N. Placenta growth factor: potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem., 269: 25646-25654, 1994.
27. Kendall, R. L., Wang, G., DiSalvo, J., and Thomas, A. Specificity of vascular endothelial growth factor receptor ligand binding domains BioChem. Btophys. Res. Commun., 201: 326-330, 1994.
28. Terman, B. I., Khandke, L., Dougher-Vermazan, M., Maglione, D., Lassam, N. J., Gospodarowicz, D., Persico, M. G., Bohlen, P., and Eisnger, M. VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors, 11: 187-195, 1994.
29. Blechman, J. M., Lev, S., Barg, J., Eisenstein, M., Vaks, B., Vogel, Z., Givol, D., and Yarden, Y. The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell, 80: 103-113, 1995.
30. Boensch, C., Kuo, M-D., Connolly, D. T., Huang, S. S., and Huang, J. S. Identification, purification and characterization of cell-surface retention sequence-binding proteins from human SK-Hep cells and bovine liver plasma membranes. J. Biol. Chem., 270: 1807-1816, 1995.
31. Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., and Ferrara, N. Dual regulation of vascular endothelial growth factor bioavailabitity by genetic and proteolytic mechanisms. J. Biol. Chem., 267: 26031-26037, 1992.
32. Gitay-Goren, H., Soker, S., Vlodavsky, I., and Neufeld, G. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem., 267: 6093-6098, 1992.
33. Jakeman, L. B., Armanini, M., Phillips, H. S., and Ferrara, N. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis Endocrinology, 233: 848-859, 1993.
34. Kendall, R. L., and Thomas, K. A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci USA, 90: 10705-10709, 1993.
35. 5 Pre-B cell-specific genes can associate with each other and with α heavy chain. J. Exp. Med., 172: 969-972, 1990.
36. Liu, F-T., Zinnecker, M., Hamaoka, T., and Katz, D. H. New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry, 18: 690-697, 1979.
37. Miles, A. A., and Miles, E. M. Vascular reactions to histamine, histamine liberators or leukotoxins in the skin of the guinea pigs. J. Physiol., 118: 228-257, 1952.
38. Scatchard, G. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci., 51: 660-672, 1949.
39. Munson, P. J., and Rodbard, D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107: 220-239, 1980.